Accretion Nutraveda (544694)

STALWART

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹200
Market Cap₹144.8 Cr
P/E Ratio55.48
ROCE56.66%
ROE—%
Dividend Yield0%
Profit Growth0%
Debt/Equity—
Sales Growth0%
SectorPharmaceuticals & Biotechnology

Accretion Nutraveda trades with a P/E ratio of 55.48, ROCE of 56.66%.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer